+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Catheter-Directed Thrombolysis Devices Market by Product Type, Material Type, Device Design, Application, Therapeutic Class, Patient Age Group, End User - Global Forecast 2025-2030- Product Image
Catheter-Directed Thrombolysis Devices Market by Product Type, Material Type, Device Design, Application, Therapeutic Class, Patient Age Group, End User - Global Forecast 2025-2030- Product Image
Sale

Catheter-Directed Thrombolysis Devices Market by Product Type, Material Type, Device Design, Application, Therapeutic Class, Patient Age Group, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6010754
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Catheter-Directed Thrombolysis Devices Market grew from USD 432.58 million in 2023 to USD 457.45 million in 2024. It is expected to continue growing at a CAGR of 5.31%, reaching USD 621.45 million by 2030.

Catheter-directed thrombolysis devices are specialized systems designed to administer clot-dissolving agents directly to the site of a thrombus, offering a minimally invasive treatment option for conditions like deep vein thrombosis and pulmonary embolism. This technique is crucial for reducing clot burden, restoring normal blood flow, and minimizing potential post-thrombotic complications. The necessity of catheter-directed thrombolysis devices lies in their targeted approach, which promotes efficacy while reducing systemic exposure to thrombolytics, thereby minimizing bleeding risks commonly associated with conventional systemic thrombolysis. These devices are primarily deployed in hospitals and specialized clinics by interventional radiologists and vascular surgeons. The market's growth is majorly influenced by the rising incidence of vascular diseases, the increasing geriatric population, and technological advancements in interventional procedures. Emerging opportunities center around improving device precision, leveraging artificial intelligence to optimize clot targeting, and enhancing drug delivery mechanisms to further reduce bleeding risks. However, the market faces challenges such as high procedural costs, potential procedural complications, and the need for skilled professionals, which can limit widespread adoption. Regulatory hurdles and reimbursement issues also vary across regions, impacting market penetration. Innovations focusing on the integration of real-time imaging and sensor technology to enhance procedural outcomes represent promising areas for research and development. Moreover, the adoption of biodegradable and biocompatible materials could address concerns related to device-related vascular injuries. In essence, the market is poised for growth, driven by technological evolutions and increasing awareness of minimally invasive therapeutic options. To capitalize on market opportunities, companies should focus on strategic collaborations with healthcare providers, invest in R&D for next-generation devices, and navigate regulatory landscapes adeptly. The dynamic nature of the market underscores the importance of adaptability and innovation to meet the evolving demands of vascular interventions effectively.

Understanding Market Dynamics in the Catheter-Directed Thrombolysis Devices Market

The Catheter-Directed Thrombolysis Devices Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Expansion of minimally invasive procedures driving the demand for catheter-directed thrombolysis devices
    • Growing investment in research and development activities to innovate catheter-based thrombolysis treatment methods
    • Increasing healthcare expenditure and focus on advanced patient care solutions
    • Collaborations and partnerships among medical device companies to enhance product reach and efficiency
  • Market Restraints
    • Strict regulatory requirements for approval of catheter-directed thrombolysis devices may delay market entry for new products
    • Risks associated with catheter-directed thrombolysis procedures, such as bleeding and infection, may limit adoption rates
  • Market Opportunities
    • Emergence of advanced imaging technologies improving precision and efficacy of thrombolysis procedures
    • Technological innovations leading to development of next-generation catheter-directed thrombolysis systems
    • Integration of artificial intelligence and machine learning in procedure planning and outcome prediction
  • Market Challenges
    • Technical complexities and expertise required for optimal operation of catheter-directed thrombolysis devices
    • Competition from alternative minimally invasive and pharmacological therapies in the thrombolysis market

Exploring Porter’s Five Forces for the Catheter-Directed Thrombolysis Devices Market

Porter’s Five Forces framework further strengthens the insights of the Catheter-Directed Thrombolysis Devices Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Catheter-Directed Thrombolysis Devices Market

External macro-environmental factors deeply influence the performance of the Catheter-Directed Thrombolysis Devices Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Catheter-Directed Thrombolysis Devices Market

The Catheter-Directed Thrombolysis Devices Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Catheter-Directed Thrombolysis Devices Market

The Catheter-Directed Thrombolysis Devices Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Catheter-Directed Thrombolysis Devices Market

The Catheter-Directed Thrombolysis Devices Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Catheter-Directed Thrombolysis Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics, Inc., Asahi Intecc Co., Ltd., Bayer AG, Boston Scientific Corporation, BTG International Ltd., Cardinal Health, Inc., Cook Medical Inc., Cordis Corporation, Endocor GmbH, iVascular S.L.U., Koninklijke Philips N.V., Medline Industries, Inc., Medtronic plc, Merit Medical Systems, Inc., MicroVention, Inc., Penumbra Inc., Stryker Corporation, Teleflex Incorporated, and Terumo Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Catheter-Directed Thrombolysis Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Accessory Devices
      • Catheter Introducers
      • Guidewires
      • Infusion Pumps
    • Thrombolytic Infusion Catheters
      • Micro Infusion Catheters
      • Standard Thrombolytic Infusion Catheters
  • Material Type
    • Nylon
    • Polyurethane
    • Polyvinyl Chloride (PVC)
    • Silicone
  • Device Design
    • Dual Lumen
    • Multi-Lumen
    • Single Lumen
  • Application
    • Acute Limb Ischemia
    • Deep Vein Thrombosis
    • Pulmonary Embolism
  • Therapeutic Class
    • Anticoagulants
    • Thrombolytics
  • Patient Age Group
    • Adults
    • Geriatrics
    • Pediatrics
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Expansion of minimally invasive procedures driving the demand for catheter-directed thrombolysis devices
5.1.1.2. Growing investment in research and development activities to innovate catheter-based thrombolysis treatment methods
5.1.1.3. Increasing healthcare expenditure and focus on advanced patient care solutions
5.1.1.4. Collaborations and partnerships among medical device companies to enhance product reach and efficiency
5.1.2. Restraints
5.1.2.1. Strict regulatory requirements for approval of catheter-directed thrombolysis devices may delay market entry for new products
5.1.2.2. Risks associated with catheter-directed thrombolysis procedures, such as bleeding and infection, may limit adoption rates
5.1.3. Opportunities
5.1.3.1. Emergence of advanced imaging technologies improving precision and efficacy of thrombolysis procedures
5.1.3.2. Technological innovations leading to development of next-generation catheter-directed thrombolysis systems
5.1.3.3. Integration of artificial intelligence and machine learning in procedure planning and outcome prediction
5.1.4. Challenges
5.1.4.1. Technical complexities and expertise required for optimal operation of catheter-directed thrombolysis devices
5.1.4.2. Competition from alternative minimally invasive and pharmacological therapies in the thrombolysis market
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Catheter-Directed Thrombolysis Devices Market, by Product Type
6.1. Introduction
6.2. Accessory Devices
6.2.1. Catheter Introducers
6.2.2. Guidewires
6.2.3. Infusion Pumps
6.3. Thrombolytic Infusion Catheters
6.3.1. Micro Infusion Catheters
6.3.2. Standard Thrombolytic Infusion Catheters
7. Catheter-Directed Thrombolysis Devices Market, by Material Type
7.1. Introduction
7.2. Nylon
7.3. Polyurethane
7.4. Polyvinyl Chloride (PVC)
7.5. Silicone
8. Catheter-Directed Thrombolysis Devices Market, by Device Design
8.1. Introduction
8.2. Dual Lumen
8.3. Multi-Lumen
8.4. Single Lumen
9. Catheter-Directed Thrombolysis Devices Market, by Application
9.1. Introduction
9.2. Acute Limb Ischemia
9.3. Deep Vein Thrombosis
9.4. Pulmonary Embolism
10. Catheter-Directed Thrombolysis Devices Market, by Therapeutic Class
10.1. Introduction
10.2. Anticoagulants
10.3. Thrombolytics
11. Catheter-Directed Thrombolysis Devices Market, by Patient Age Group
11.1. Introduction
11.2. Adults
11.3. Geriatrics
11.4. Pediatrics
12. Catheter-Directed Thrombolysis Devices Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Hospitals
12.4. Specialty Clinics
13. Americas Catheter-Directed Thrombolysis Devices Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Catheter-Directed Thrombolysis Devices Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Catheter-Directed Thrombolysis Devices Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2023
16.2. FPNV Positioning Matrix, 2023
16.3. Competitive Scenario Analysis
16.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET RESEARCH PROCESS
FIGURE 2. CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2023 VS 2030 (%)
FIGURE 15. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2023 VS 2030 (%)
FIGURE 17. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 19. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 23. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 28. CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 29. CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET DYNAMICS
TABLE 7. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY CATHETER INTRODUCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MICRO INFUSION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY STANDARD THROMBOLYTIC INFUSION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY NYLON, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY SILICONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DUAL LUMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MULTI-LUMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACUTE LIMB ISCHEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ANTICOAGULANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 71. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 72. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 73. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 74. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 76. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 77. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 80. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 81. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 83. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 85. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 86. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 107. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 109. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 110. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 118. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 119. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 120. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 121. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 123. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 124. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 127. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 128. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 129. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 130. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 132. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 133. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 136. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 138. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 141. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 142. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 145. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 146. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 147. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 148. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 150. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 151. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 154. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 155. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 156. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 157. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 159. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 160. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 163. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 164. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 165. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 168. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 169. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 172. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 173. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 174. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 175. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 177. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 181. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 182. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 183. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 184. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 186. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 187. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 190. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 191. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 192. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 195. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 196. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 199. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 200. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 201. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 202. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 204. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 205. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 208. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 209. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 210. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 213. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 214. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 225. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 227. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 228. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 229. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 230. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 232. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 233. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 236. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 237. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 238. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 239. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 241. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 242. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 245. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 246. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 247. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 248. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 250. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 251. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 254. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 255. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 256. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 257. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 259. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 260. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 263. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 264. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 265. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 266. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 268. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 269. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 278. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. ITALY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. ITALY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 281. ITALY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
TABLE 282. ITALY CATHET

Companies Mentioned

The leading players in the Catheter-Directed Thrombolysis Devices market, which are profiled in this report, include:
  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Asahi Intecc Co., Ltd.
  • Bayer AG
  • Boston Scientific Corporation
  • BTG International Ltd.
  • Cardinal Health, Inc.
  • Cook Medical Inc.
  • Cordis Corporation
  • Endocor GmbH
  • iVascular S.L.U.
  • Koninklijke Philips N.V.
  • Medline Industries, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroVention, Inc.
  • Penumbra Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Medical Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages190
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 457.45 Million
Forecasted Market Value ( USD ) by 2030 $ 621.45 Million
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Catheter-Directed Thrombolysis Devices Market Report by Delivery Mode, End User, and Region 2024-2032 - Product Image

Catheter-Directed Thrombolysis Devices Market Report by Delivery Mode, End User, and Region 2024-2032

  • Report
  • 149 Pages
  • Global
From
Transcatheter Tricuspid Valve Intervention / Interventional Therapy For Pulmonary Embolism, An Issue of Interventional Cardiology Clinics. The Clinics: Internal Medicine Volume 7-1 - Product Image

Transcatheter Tricuspid Valve Intervention / Interventional Therapy For Pulmonary Embolism, An Issue of Interventional Cardiology Clinics. The Clinics: Internal Medicine Volume 7-1

  • Book
Ischemic Stroke - Pipeline Insight, 2024 - Product Image

Ischemic Stroke - Pipeline Insight, 2024

  • Clinical Trials
  • 180 Pages
  • Global
From
Intravascular Catheters Global Market Report 2024 - Product Image

Intravascular Catheters Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Pulmonary Embolism Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Pulmonary Embolism Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 136 Pages
  • Global
From

About the Catheter Directed Thrombolysis Market

Catheter Directed Thrombolysis (CDT) is a minimally invasive procedure used to treat deep vein thrombosis (DVT). It involves the use of a catheter to deliver thrombolytic drugs directly to the clot, which helps to dissolve it. CDT is a relatively new procedure and is becoming increasingly popular as an alternative to traditional treatments such as anticoagulants and surgical thrombectomy. CDT is used to treat DVT in the legs, arms, and other parts of the body. It is also used to treat pulmonary embolism, a potentially life-threatening condition caused by a blood clot in the lungs. CDT is a safe and effective treatment option for many patients, and it has been shown to reduce the risk of recurrent DVT and pulmonary embolism. The Cardiovascular Drugs market includes a variety of products used to treat cardiovascular diseases, including CDT. CDT is used to treat a variety of conditions, including DVT, pulmonary embolism, and other cardiovascular diseases. Some companies in the CDT market include AngioDynamics, Boston Scientific, and Medtronic. These companies offer a variety of products for CDT, including catheters, thrombolytic drugs, and other medical devices. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.